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Intercellular adhesion molecule-1 (ICAM-1) is 
strongly expressed by human epidermal keratinocytes 
during the course of inflammatory skin diseases. To 
test the possibility that reactive oxygen species pro-
duced in the skin during an inflammatory response 
affect ICAM-1 expression, cultured human epidermal 
keratinocytes were treated with HzOz at concentra-
tions that did not damage the cells, and cell-surface 
ICAM-1 expression was analyzed. Expression of 
ICAM-1 was induced on keratinocytes by treatment 
with 300 J.lM HzO z for 1 h. The antioxidant N-acetyl-
L-cysteine strongly inhibit~d ~zOz-induce~ !C~-1 
expression, whereas the antIOXidants pyrrohdlDe dlth-
iocarbamate and a-tocopherol were less inhibitory. N-
acetyl-L-cysteine also suppressed keratinocyte surface 
expression ofICAM-1 induced by the cytokines inter-
feron-y (IFN-y) or tumor necrosis factor-a (TNF-a), 
T he adhesion between leukocytes and target cells through interCellu.la.r adhesion m~lecule-l (IC~-l. CD54) and its ligands plays an Important role In a wide variety of immune reactions. Clinically, ICAM-1 expression has been observed in the epidermis of 
many kinds of inflammatory skin diseases, including subacute cuta-
neous lupus erythematosus, erythema multiforme, pemphigus vul-
garis, vitiligo, contact hypersensitivity, lichenoid tissue reaction 
[1,2]' and psoriasis [1.3) . Pharmacologic modulati~n of ICAM~l 
,I expression in inflammatory skin diseases is an attractive therap~utlc 
strategy. However, little is known about the r~gulatory mec.hamsms 
of ICAM-l expression in the course of skin lllflammatlon. Al-
though ICAM-l is constitutively expressed on the surface of ma~y 
kinds of cells such as leukocytes, fibroblasts, and some endothelIal 
cells [4). basal ICAM-l on keratinocytes is very low (5) . Expression 
of ICAM-l molecules on the surface of keratinocytes is rapidly 
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whereas pyrrolidine dithiocarbamate and a-tocoph-
erol suppressed IFN-y-induced surface expression but 
not TNF-a - induced expression. We found that N -ace-
tyl-L-cysteine treatment reduced ICAM-1 mRNA 
levels when keratinocytes were stimulated with either 
IFN-y or TNF-a; however, pyrrolidine dithiocarba-
mate and a-tocopherol had no effect on either IFN-y-
or TNF-a-induced ICAM-1 mRNA levels. Our results 
indicate that reactive oxygen species may be involved 
in the skin inflammatory process by increasing epider-
mal ICAM-1 expression and that some antioxidants 
may be effective in suppressing the epidermal ICAM-1 
expression induced by reactive oxygen species and cy-
tokines in inflammatory skin diseases. Key words: hy-
drogen peroxide/reactive oxygen species/interferon-y/tumor 
necrosis factor-a. J Invest Dermato1103:791-796, 1994 
induced by numerous stimuli. including cytokines (interferon-y 
[IFN-Y) [5- 8) and tumor necrosis factor-a [TNF-a) (5)) and phor-
bol 12-myristate 13-acetate [7]. 
Damage induced by reactive oxygen species is thought to playa 
role in the pathogenesis of inflammatory skin diseases (9). High 
local levels of superoxides, including H 20 2 , are produced as a result 
of the respiratory burst of infiltrating polymorphonuclear leuko-
cytes and macrophages in the inflamed skin (9). Iyer et al (10) esti-
mated that H 20 2 concentrations within leukocytes during phago-
cytosis may vary from 1 to 100 mM. At the time superoxides are 
produced, ICAM-l molecules are highly expressed on the cell sur-
face of involved epidermal keratinocytes. ICAM-l upregu lation on 
the keratinocyte cell surface allows leukocytes and macrophages to 
easily attack the keratinocytes in skin inflammation. We hypothe-
sized that reactive oxygen species may promote the inflammation 
process by activating ICAM-l expression. To test this hypothesis, 
we used H 20 2 at a concentration that does not cause cell damage to 
generate reactive oxygen species and analyzed the effect of different 
kinds of antioxidants on ICAM-l expression by keratinocytes. We 
also looked at the effect of antioxidants on cytokine-mediated 
ICAM-l expression. 
MATERIALS AND METHODS 
Reagents Recombinant human TNF-a was purchased from R&D Sys-
tems (Minneapolis, MN). Recombinant IFN-y was from UBI (Lake Placid, 
NY) and Genzyme Co. (Cambridge, MA). N-aceryl-L-cysteine (NAC) and 
pyrrolidine dithiocarbamate (PDTC) were obtained from Sigma (St. Louis. 
MO) . H20 2 and D-a-tocopherol were from EM Science (Gibbstown, NJ) 
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and Eastman Kodak Co. (Rochester, NY), respectively. a-tocopherol was 
dissolved in ethanol, and PDTC in Dulbecco's phosphate-buffered saline. 
NAC was adjusted to pH 7.4 by addition of NaOH. Anti-human ICAM-1 
(CD54) mouse immunoglobulin (Ig)G1 monoclonal antibody (84H10) 
conjugated with fluorescein isothiocyanate and phycoerythrin were ob-
tained from AMAC, Inc. (Westbrook, ME), and anti-HLA-DR monoclonal 
antibody conjugated with fluorescein isothiocyanate was from Becton-
Dickinson (Mountain View, CAl. The isorypic control antibody was fluo-
rescein isothiocyanate -conjugated 19G1 from Coulter Immunology (Hia-
leah, FL). 
Cell Culture and Analysis Normal human keratinocytes were pur-
chased from Clonetics Corp. (San Diego, CAl and grown in a modified 
serum-free MCBD 153 medium (KGM, Clonetics Corp.) . The second- or 
third-passage keratinocytes were plated in six-well culture plates (Falcon, 
Lincoln Park, NJ) or in 75-cm2 flasks (Corning Inc., Corning, NY) at 2500 
cells/cm2 • After 7 d, the medium was replaced with modified serum-free 
MCBD 153 medium unsupplemented with growth factors (KBM, Clone-
tics Corp.), and experiments were irutiated. Keratinocytes were used at third 
or fourth passage for the experiments. Cell viabiliry was determined by 
trypan blue dye exclusion. For analysis by immunofluorescence flow cytom-
etry, keratinocytes cultured in six-well plates were released with phosphate-
buffered saline containing 10 mM ethylenediamine tetraacctic acid (EDT A) 
for 45 min at 37 °C. Washed keratinocytes were stained with conjugated 
anti - ICAM-1 monoclonal antibodies or isorypic control fluorescein 
isothiocyanate - conjugated IgG 1 for 30 min at 4 ° C. The keratinocytes 
were washed three times and either analyzed immediately or fixed with 
phosphate-buffered saline containing 0.05% para formaldehyde . Fluores-
cence-activated cell sorter analysis was performed using a Coulter Elite 
flow-cytometry system (Hialeah, FL) . Cell shape and granulariry were ana-
lyzed by forward light scatter and 90° light scatter. For determining the 
number ofICAM-positive cells, control and H20 2-treated cells were stained 
with isotypic control antibody and analyzed. The control and treated popu-
lations stained with isorypic control antibody gave identical histograms, and 
a gate was set at the upper 2% for these cell populations. Cells were lCAM-1 
positive when the fluorescence was above this gate. 
Northern Blot Analysis Total RNA was extracted from 3 X 106 kerati-
nocytes using guanidine thiocyanate and phenol-chloroform extractions by 
the method of Chomczynski and Sacchi [11). RNA (10 f.lg) was electrophor-
esed in 1% agarose-formaldehyde gels [12) and transferred to Nytran 
(Schleicher and Schuell Inc., Keene, NH) as per the manufacturer's protocol. 
Blots were first hybridized with a PstI, 463-base pair (bp) portion of the 
human ICAM-1 eDNA [13]. To tcst for equivalent loading, transfer, and 
integriry of the RNA, the blots were stripped and hybridized with a 1.1-kb 
EcoRl fragment of the cDNA for the human house-keeping gene of glycer-
aldehyde 3-phosphate dehydrogenase (G3PDH) (Clontech, Palo Alto, CAl 
[14) . Both probes were radiolabeled with [a-32P)dCTP (NEN, Boston, MA) 
by random priming. Relative band intensities in slot-blot were determined 
by densitometry using Image Quant instalIed on Computing Densitometer 
(Molecular Dynamics, Sunnyvale, CAl. 
RESULTS 
Induction ofKeratinocyte ICAM-1 Expression by H 20 2 Ker-
atinocyte expression of ICAM-l was measured by immunofluores-
cence flow cytometry. H 20 2 treatment, 300,uM for 4 h, did not 
alter cell shape, granularity, or autofluorescence, but did signifi-
cantly increase the number of cells expressing ICAM-1. In the ex-
periment shown in Fig 1, untreated populations were 6.5 + 0.8% 
ICAM-l positive (n = 3), and H 20 2-treated populations were 
37.6 + 1.5% ICAM-1 positive (n = 3). ICAM-l induction was 
both H 20 2 concentration and time dependent. Expression of 
ICAM-l was initiated by 50,uM H 20 2 , and maximal ICAM-l ex-
pression was reached at 300 JiM H 20 2 (Fig 2a). Keratinocytes 
began expressing ICAM-1 after only 1 h incubation with 300 ,uM 
H 20 2 (Fig 2b). In this experiment, incubation for up to 6 h w ith 
300 f.lM H 20 2 induced ICAM-1 expression on the cell surface of 
only 20% of keratinocytes. Even prolonged incubation, up to 24 h 
with H 20 2 • did not further enhance keratinocyte expression of 
ICAM-1. Incubation with H 20 2 at 300,uM for 24 h showed no 
effect on cell viability (cell viability > 89%). whereas higher con-
centrations adversely affected viability. Incubation with increasing 
concentrations of H 20 2 up to 1 mM did not induce HLA-DR ex-
pression on keratinocytes «0.6% of cells HLA-DR positive) (Fig 
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2a) . Based on these studies, the optiInal conditions for ICAM-1 
induction on keratinocytes were 300 ,uM H 20 2 for 4 h. 
Suppression ofH20 2-Induced Cell-Surface ICAM-1 Expres-
sion by Antioxidants To clarify whether reactive oxygen spe-
cies induced by H 20 2 promoted ICAM-l expression, the antioxi-
dants NAC (20 mM), POTC (100,uM), and a-tocopherol 
(100,uM) were added 1 h before the addition of H 20 2 (300 ,uM) 
(Fig 3). The antioxidant concentrations used in this experiment 
were determined to be th e maximal concentrations that did not 
affect cell viability. Preincubation with NAC ma.rkedly suppressed 
cell-surface ICAM-l expression induced by H 20 2 • from 15.5% to 
2.6% of the cells. In the presence ofPOTC or a-tocopherol, H 20 2-
induced ICAM-l was expressed on 11.3% and 12.4% of the kerati-
nocytes, respectively. The antioxidants alone did not affect the very 
low constitutive ICAM-l expression on the surface ofkeratinocytes 
(data not shown). 
Suppression of TNF-a- and/or IFN-y-Induced Keratino-
cyte ICAM-l Expression by Antioxidants To test the possi-
bility that antioxidants inhibit cytokine-induced ICAM-l expres-
sion by keratinocytes, we treated keratinocytes with both cytokines 
and antioxidants. First, the concentrations and time courses for op-
timal ICAM-l induction by IFN-y and TNF-a were determined 
(data not shown). More than 90% of keratinocytes expressed 
ICAM-l after only 6 h incubation with 670 U/ml ofIFN-y. Incu-
bation with 500 U/ml ofIFN-y for 4 h induced 15 -40% ofkerati-
nocytes to become ICAM- l positive. Maximal expression of 
ICAM-l by TNF-a was less than 75% ofkeratinocytes, even when 
keratinocytes were treated for as much as 24 h at 10 ng/ml of 
TNF-a. Treatment with 500 pg/ml of TNF-a for 18 h induced 
35-60% of keratinocytes to be ICAM-l positive. As reported by 
others [6,15] , IFN-y but not TNF-a induced HLA-OR expression 
by keratinocytes (data not shown). 
When keratinocytes were strongly stimulated with IFN-y (670 
U/ml, longer than 6 h) or TNF-a (10 ng/ml, longer than 6 h), all 
100~-------,---------------------------, 
75 ~ 
50 
-I 
~ 25 
6 
>-
Control a 
~ O -r-------~~~~~~~------------------~ Q) 
f 75 !IJII\ 
50 -
25 - !~ 
\\ 
b 
v" \l'rJ' \.\, 
0"------1·"\~'~,,-2-=l=~~~-.....------___l 
.1 1 10 100 1000 
Relative Fluorescence Intensity 
(Channel Number X 10-1) 
Figure 1. Induction of cell-surface ICAM-t on keratinocytes by 
H 20 2 • Keratinocytes were untreated (a) or treated (b) with 300 f.lM H20 2 
for 4 h. Cells were labeled with fluorescein-conjugated anti-human lCAM-
1 monoclonal antibody (thick /iI/e) or with isorypic control monoclonal 
antibody, fluorescein-conjugated IgG, (tltill lille) , and analyzed by immuno-
fluorescence flow cytometry as described in Materials and Methods. 
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Figure 2. Induction of ICAM-l is H20 2 concentr~tion dependent 
and time dependent. Kerantinocytes were mcubated With mcreasmg con-
centrations of H20 2 (25 -1000 liM) for 4 h (a) or with H20 2 (300 liM) for 
1-24 h (b). Keratinocytes were labeled with f1uor~scein-~onjugated anti-
human ICAM-l monoclonal antibody or fluorescem-cOllJugated anti-hu-
man HLA-DR monoclonal antibody as described in Materials alld Methods. 
Cells were analyzed by immunofluorescence flow cytometry. Data are given 
as mean percent of ICAM-l- positive cells ± SD (solid lille) or percent 
HLA-DR-positive cel ls (dashed lille). 
of the antioxidants failed to suppress ICAM-1 expression (data not 
shown). However, when keratinocytes were stimulated with sub-
optimal IFN-y (500 D/ml for 4 h), addition of NAC (20 mM) 
reduced cell-surface ICAM-1 expression from 26.4% to 6.9% (Fig 
4b). PDTC (10 .uM) and a-tocopherol (lOO.uM) also suppressed 
ICAM-l expression from 26.4% to 10.0% and 5.3%, respectively 
(Fig 4c,d). When keratinocytes were stimulated with suboptimal 
TNF-a (500 pg/ml for 18 h), NAC slightly suppressed ICAM-l 
expression, reducing ICAM-l- positive cells from 56.0% t.o 36.4% 
(Fig 5b) . PDTC and a-tocopherol showed no effect (Flg 5c,d). 
Treatment ofkeratinocytes with suboptimal concentrations of both 
IFN-y (335 U /ml) plus TNF-a (500 pg/ml) for 6 h induced 98.9% 
of the cells to be ICAM-l positive. In this experiment, addition of 
NAC, PDTC, and a-tocopherol did not affect the percentage of 
ICAM-l- positive keratinocytes (97.4%, 98.5%, and 98.5%, re-
spectively). 
Accumulation of Keratinocyte ICAM-l mRNA by TNF-a 
and/or IFN-y and Suppression by Antioxidants Keratino-
cytes were pretreated with antioxidants for 1 h and incubated with 
respective cytokines in the presence of antioxidants for 4 h. Total 
cellular RNA then was isolated and ICAM-l mRNA accumulation 
compared by Northern blot analys is (Fig 6) . Keratinocytes had very 
low but detectable levels of ICAM-l mRNA when they were not 
stimulated. IFN-y (335 U /ml) induced a 35-fold increase in ICAM-
1 mRNA levels compared with the unstimulated state. When IFN-
y-stimulated keratinocytes were treated with NAC, ICAM-l 
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Figure 3. Suppression ofH20.-induced cell-surface ICAM-l expres-
sion by antioxidants. Keratinocytes were preincubated with NAC 
(20 mM). PDTC (100 liM), or a-tocopherol (100 liM) for 1 h and then 
incubated with H20 2 (300 liM) for 1 h. Keratinocytes were then labeled 
with fluorescein-co~ugated anti-human ICAM-l monoclonal antibody as 
described in Materials a"d Methods. Cells were ana lyzed by immunofluores-
cence flow cytometry. Data are given as percent ofICAM-l-positive cells. 
These results are the mean ± SD from three independent experiments. 
mRNA levels were only 37% of mRNA levels from IFN-y-
stimulated cells without antioxidants. Neither PDTC nor a-to-
copherol significantly affected IFN-y-induced ICAM-l mRNA 
accumulation. TNF-a (500 pg/ml) induced low levels ofICAM-l 
mRNA: a sevenfold increase compared with the unstimulated state. 
NAC also suppressed ICAM-1 mRNA accumu lation induced by 
TNF-a; mRNA levels of NAC-treated keratinocytes were 32% of 
those of TNF-a-stimulated keratinocytes. PDTC and a -tocoph-
erol had little effect on TNF-a-induced ICAM-1 mRNA levels. 
Treatment of keratinocytes with both TNF-a (500 pg/ml) and 
IFN-y (335 U /m1) displayed a synergistic effect on ICAM-l 
mRNA accumulation, as previous ly reported [16), showing a 76-
fold increase in ICAM-l mRNA levels. Treatment ofTNF-O' plus 
IFN-y-stimulated keratillocytes with NAC, PDTC, and a-to-
copherol showed 34%, 81 %, and 85% of the ICAM-l mRNA levels 
from TNF-a plus IFN-y-stimulated keratinocytes without antiox-
idants. 
DISCUSSION 
To explore whether reactive oll.)'gen species can induce ICAM-l 
expression, we stimulated keratinocytes with H 20 2 • H 20 2 is a sim-
ple molecule produced by polymorphonuclear leukocytes and mac-
rophages during inflammation. It works on the cell surface and also 
permeates the cell, where it is converted into hydroxyl radical 
(. OH) [1 7] . Keratinocytes treated ill IIitro with up to 700.uM H 20 2 
undergo oxidative stress but recover within 90 min [1 8]. We found 
that low concentrations ofH20 2 stimulated keratinocyte ICAM-l 
expression without affecting cell viability. However, H 20 2 did not 
induce complete ICAM-l expression on keratinocytes, nor did 
H 20 2 induce major histocompatibility complex class II expression 
by keratinocytes. Prolonged treatment of keratinocytes with 
300 .uM H 20 2 for 24 h never induced more than 35% of the cells to 
be ICAM-l positive. This pattern of activation differs from that 
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Figure 4. Suppressive effect of antioxidants on IFN-y-induced cell-
surface ICAM-l expression on keratinocytes. Keratinocytes stimulated 
with IFN-y (500 U Iml) for 4 h are shown by a Ilfavy litle. Thi tl line indicates 
keratinocytes unstimulated (a) and pre incubated with NAC (20 mM) (b), 
PDTC (10 11M) (c), or a-tocopherol (100 11M) (d) for 1 h, then incubated 
with both antioxidant and IFN-y (500 U/ml) for 4 h. Keratinocytes were 
labeled with fluorescein-conjugated anti-human ICAM-l monoclonal anti-
body as described in Materials and Methods. Cells were analyzed by immuno-
fluorescence flow cytometry. Data are given as histograms of cell number 
versus fluorescence intensity. Histograms represent one of three essentially 
identical experiments. 
seen with IFN-y and TNF-Q. At optimal concentrations, IFN-y 
activated more than 90% of keratinocytes to express ICAM-l and 
HLA- D R. Like HzOz, TNF-Q did not induce HLA-D R expression, 
but unlike HzO z, TNF-Q at optimal concentrations induced >70% 
of keratinocytes to be ICAM-l positive. In preliminary experiments 
using reverse transcriptase and polymerase chain reaction amplifica-
tion, we have been unable to detect increased ICAM-1 mRNA at 4 
and 24 h after treatment. In contrast, Bradley et al [19] found 
ICAM-t mRNA to be transiently increased after HzOz treatment of 
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Figure 5. Differential effect of antioxidants on TNF-a-induced cell-
surface ICAM-l expression on keratinocytes. Keratinocytes stimulated 
with TNF-a (500 pg/ml) for 18 h are shown by a heavy litle. T hin li" e 
indicates keratillocytes unstimulated (a) and preincubated with NAC 
(20 mM) (b) , PDTC lO/IM) (c), or a -tocopherol (lOOI1M) (d) for 1 h, 
then incubated with both antioxidant and TNF-a (500 pg/rnl) for 18 h. 
Keratinocytes were labeled with phycoerythrin-conjugated anti-human 
ICAM-l monoclonal antibody as described in Materials atld Methods. Cells 
were analyzed by immunofluorescence flow cytometry. Data are given as 
histograms of cell number versus fluorescence intensity. Histograms repre-
sent onc of three essentially identical experiments. 
human umbilical vein endothelial cells. We speculate that HzO z 
works at a post-transcriptional level in keratinocytes. One explana-
tion may be that cell-surface ICAM-l is normally present on kerati-
nocytes but is masked in some way, and H Z0 2 treatment exposes the 
cell-surface ICAM-1. Another possibility is that HzOz may stimu-
late the transport of preformed ICAM-l from the cytoplasm to the 
cell surface of keratinocytes. 
We found a differential effect of various types of antioxidants on 
HzOz-induced ICAM-l expression by keratinocytes. NAC inhib-
ited HzOz-induced ICAM-l expression, whereas both PDTC and 
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Figure 6. Accumulation ofkeratinocyte ICAM-l mRNA by TNF-a 
and IFN-y and suppression by antioxidants. Northern blot analysIs of 
total cellular RNA (10 I1g) using 32P_labeled cDNA probes encodmg for 
ICAM-l and G3PDH (a) was performed as desuibed in Mat~rials alld Meth-
ods. Keratinocytes were unstimulated (falle 1) or II1cubated with IFN-y (335 
U Iml) (falles 2, 6, 10, alld 14), TNF-a (500 pg/ml) (falles 3, 7, 11, atld 15), 
or TNF-a (500 pg/ml) plus IFN-y (335l! I ml) (fotles 4, 8, 12, alld 1~) for 
4 h. One hour before the addition of cytokll1es. kerattnocytcs were premcu-
bated with NAC (20 mM) (falles 5 - 8), PDTC (10 tiM) (falles 6-12), or 
a-tocopherol (100 11M) (falles 13-16). Relative ICAM-l mRNA levels to 
G3PDH mRNA levels are shown as the percentage of maximal ICAM-l 
mRNA expression by keratinocytes (TNF-a plus IFN-Y) (b). 
a-tocopherol were less inhibitory. NA~ can s.erv~ as a precursor ~or 
biosynthesis of glutathione. a cytosohc antioxidant. thereby 111-
creasing the intracellular glutathione level [9]. Endogenous gluta-
thione peroxidase catalyzes the reduc~ion of H.20 2 to. O 2 and H 20 
using glutathione as a cofactor. NAC IS an effiCient t1uol source and 
can reduce intracellular H 20 2 and directly capture other reactive 
oxygen species such as . OH. Although the molecular p~operties of 
PDTC are not clear. it seems to work as a metal-chelat1l1g reagent 
and as a thiol compound [20]. Metal chelators are t1~ought to re-
move catalytic iron and strongly prevent the formatIOn of . OH. 
D-a-tocopherol. a potent lipid-soluble antioxidant. is thought to 
trap' OH and organic free radicals such ~s derived from lipid perox-
idation [9]. Potentially damaging reactive oxygen species that are 
produced by H 20 2 • as in our experiments. are thought to beH20 2 
itself and , OH. Strong inhibition by NAC and weak I11hlbltlon by 
PDTC and a-tocopherol of H 20 2-induced ICAM-1 expression 
may indicate a more important role for H20 2 than for' OH in the 
ICAM-1 expression pathway in our system. 
U sing these antioxidants. we examined the possible role of reac-
tive oxygen species in cytokine-induced lCAM-l expression by 
keratinocytes. Unlike H 20 2 , high concentrations of IFN-y and 
TNF-a induce 60 - 75% of keratinocytes to express ICAM-l. At 
these optimal conditions, the antioxidants did not alter lCAM-l 
expression. However, at suboptimal concentrations ofTNF-a and 
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lFN-y, the antioxidants clearly inhibited lCAM-l cell-surface ex-
pression. Whereas IFN-y- induced ICAM-l protein expression was 
suppressed by NAC, PDTC, and a -tocopherol, ICAM-l mRNA 
accumulation was suppressed only by NAC. Both ICAM-l mRNA 
accumulation and ICAM-l protein expression induced by TNF-a 
were suppressed by NAC, but not by PDTC and a-tocopherol. 
Whereas TNF-a plus IFN-y- induced ICAM-l mRNA accumula-
tion was strongly inhibited by NAC and moderately by PDTC and 
a-tocopherol, cell-surface ICAM-l expression was not affected by 
any of the antioxidants tested. The stronger suppression with NAC 
and weaker suppression with PDTC and a-tocopherol suggest that 
H 20 2 levels may be involved in ICAM-l upregulation by these 
cytokines. However, because PDTC and a -tocopherol reduced 
ICAM-l expression in some conditions, the involvement of· OH 
and other reactive oxygen species cannot be excluded. Furthermore, 
differences in the suppressive effects on ICAM-l mRNA accumula-
tion and ICAM-1 protein expression suggest that antioxidants may 
affect mRNA levels and protein expression independently. We 
have not yet determined whether the antioxidants affect transcrip-
tional rates andjor mRNA stability . The effects of antioxidants on 
translation, post-translational modification. and jor processing are 
yet to be explored. 
A recent hypothesis speculates that some cellular stimuli, includ-
ing TNF and interleukin-1. might work through second messen-
gers such as reactive oxygen species on nuclear factor KB (NF-KB) to 
activate transcription [17,21]. The activation of NF-Jd3 by treat-
ment with H20 2 has also been reported for many cell lines. includ-
ingJurkat T cells, Ltk- mouse fibroblast line, and 70Z/3 pre-B cell 
line [17]. This suggests that NF-KB is the common factor in the 
activation systems we have studied. NF-KB is an inducible DNA-
binding protein implicated in the transcriptional induction of many 
genes [22]. In the 5' flanking region of the human ICAM-1 gene, at 
least four putative NF-KB binding sites have been reported [23 - 25]. 
Future studies should examine a role for reactive oxygen species in 
NF-KB-directed activation ofICAM-1 in keratinocytes following 
treatment with TNF-a or IFN-y. 
To date, there is no effective pharmacologic means by which to 
decrease cytokine-induced ICAM-1 upregulation in keratinocytes. 
TNF-a-andjor IFN-y-induced ICAM-l expression in keratino-
cytes is not controlled by strong anti-inflammatory or potential 
immunomodulative reagents such as corticosteroids [1] , cyclosporin 
A [1] , retinoic acids [1,26], 1,25-dihydroxyvitamin D3 [27]. and 
griseofulvin [28]. Ultraviolet radiation, which is used for many 
inflammatory skin diseases, inhibits keratinocyte ICAM-1 induc-
tion by IFN-y 24 h after irradiation; however, ICAM-1 expression 
is significantly enJlanced at 48 - 96 h after ultraviolet irradiation 
[29] . Antioxidants are rarely used clinically in dermatology. The use 
of superoxide dismutase to prevent reactive oxygen species-induced 
damage is one exception that has been studied thoroughly [9]. Pso-
riatic epidermal cells are reported to have increased ICAM-l ex-
pression, especially at the tips of the dermal papillae [3] , and probu-
col, a potent antioxidant, has been reported sporadically as useful in 
some psoriatic patients [30]. Our results indicate that some antioxi-
dants may be effective in suppressing epidermal ICAM-1 expres-
sion. thus resulting in a decrease ofleukocyte adhesion to epidermal 
cells and subsequent remission of inflammatory skin diseases such as 
psoriasis. We propose that antioxidants are pharmaceutically worth 
considering in the treatment of inflammatory skin disorder. 
We thallk Philip L. Smith Jor DNA ofigomers sYllthesis. We are grateJufto Drs. 
George Ku alld Craig E. Thomas Jor useJuf discussions and /0 Dr. Terry L. Bowfin 
Jor cOII/illUOIiS cllcoliragellJellt. MI thanks Dr. Richard L. jacksoll Jor providing all 
opportullity /0 do research itl the U.S.A. 
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